June 28, 2025 a 07:43 am
STE: Fundamental Ratio Analysis - STERIS plc
STERIS plc, operating in infection prevention, showcases consistent financial health and steady growth potential. With diversified business segments, it continues to serve critical sectors effectively. This establishment since 1985 remains a reliable choice for investors interested in the healthcare sector.
Fundamental Rating
The fundamental analysis reflects a solid performance with room for improvement in certain areas, as depicted in the ratings.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
A look back at the historical scores signals consistent performance, with slight variability reflected over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-27 | 3 | 4 | 4 | 5 | 3 | 1 | 2 |
| Previous | 0 | 4 | 4 | 5 | 3 | 1 | 2 |
Analyst Price Targets
Analysts predict a stable price trajectory, with minimal variance between high and low target prices.
| High | Low | Median | Consensus |
|---|---|---|---|
| $265 | $245 | $260 | $256.67 |
Analyst Sentiment
The sentiment towards STERIS remains positive, with a majority advocating for a 'Buy' stance.
| Recommendation | Number | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 3 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
STERIS plc presents a robust investment with a stable financial foundation and consistent performance across key financial areas. The positive analyst sentiment and precise target projections augment its investment appeal. However, limited growth in certain metrics like Price to Earnings may warrant keen monitoring. Overall, its diversified operations enhance resilience, making it a valuable addition to a healthcare-focused portfolio.